Arcellx’s $112 Million Public Offering

Wilson Sonsini advised Arcellx on the deal.Arcellx, a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here